| 1 | adjusted | 12,840 |
| 2 | unadjusted | 1,115 |
| 3 | peto | 802 |
| 4 | multivariable-adjusted | 136 |
| 5 | multivariate-adjusted | 81 |
| 6 | score-adjusted | 34 |
| 7 | cluster-adjusted | 24 |
| 8 | per-allele | 18 |
| 9 | model-adjusted | 14 |
| 10 | k-m | 9 |
| 11 | yousilin | 8 |
| 12 | multiple-adjusted | 7 |
| 13 | -adjusted | 6 |
| 14 | erbe | 6 |
| 15 | jewett | 6 |
| 16 | uhn | 6 |
| 17 | atom-based | 5 |
| 18 | confounder-adjusted | 5 |
| 19 | graft-level | 5 |
| 20 | hh₃ | 5 |
| 21 | 10= | 4 |
| 22 | post15 | 4 |
| 23 | re=eu | 4 |
| 24 | score- | 4 |
| 25 | top-decile | 4 |
| 26 | 24hr-1 | 3 |
| 27 | collected.the | 3 |
| 28 | eou | 3 |
| 29 | ho2c-peg600-dtcz | 3 |
| 30 | mic50/90 | 3 |
| 31 | sur1 | 3 |
| 32 | tiselius | 3 |
| 33 | β=0.005 | 3 |
| 34 | 1.865 | 2 |
| 35 | 1/year | 2 |
| 36 | 100/90.9 | 2 |
| 37 | 100mg/animal | 2 |
| 38 | 1mg/kg/hn/saline | 2 |
| 39 | 22,937 | 2 |
| 40 | 42°c±0.5°c | 2 |
| 41 | 5.0/1000 | 2 |
| 42 | 52.8°c | 2 |
| 43 | antirenin | 2 |
| 44 | between-components | 2 |
| 45 | carafate | 2 |
| 46 | constant- | 2 |
| 47 | corixa | 2 |
| 48 | e-flip | 2 |
| 49 | ear-based | 2 |
| 50 | end-of-period | 2 |
| 51 | framingham- | 2 |
| 52 | frequency*severity | 2 |
| 53 | gammagard | 2 |
| 54 | hadji | 2 |
| 55 | hbiii | 2 |
| 56 | insulet | 2 |
| 57 | interview* | 2 |
| 58 | kiddie-schedule | 2 |
| 59 | lecg | 2 |
| 60 | lesion-to-pancreas | 2 |
| 61 | mccall | 2 |
| 62 | mersilene™ | 2 |
| 63 | model-generalized | 2 |
| 64 | most-diseased-segment | 2 |
| 65 | near-stasis | 2 |
| 66 | nitta | 2 |
| 67 | pgr-poor | 2 |
| 68 | pondered | 2 |
| 69 | rem3 | 2 |
| 70 | resynchronization/defibrillation | 2 |
| 71 | shiken | 2 |
| 72 | single-decrement | 2 |
| 73 | ugeskrift | 2 |
| 74 | utw | 2 |
| 75 | δbsg=3 | 2 |
| 76 | −0.33 | 2 |
| 77 | 'needs | 1 |
| 78 | 'self-efficacy | 1 |
| 79 | 'validity | 1 |
| 80 | +0.045 | 1 |
| 81 | +1.1/minute | 1 |
| 82 | -0.00094 | 1 |
| 83 | -1.8ml/min | 1 |
| 84 | -13.85 | 1 |
| 85 | -2-0 | 1 |
| 86 | -23.9±4.7 | 1 |
| 87 | -29.3±2.7 | 1 |
| 88 | -777.57 | 1 |
| 89 | .66±.60w/kg | 1 |
| 90 | //www.annualreviews.org/catalog/pubdates.aspx | 1 |
| 91 | //www.cochrane.org | 1 |
| 92 | //www.cochrane.org/ | 1 |
| 93 | 0-5-point | 1 |
| 94 | 0-iic | 1 |
| 95 | 0.1055 | 1 |
| 96 | 0.5-year | 1 |
| 97 | 0.87±1.21 | 1 |
| 98 | 0.94±1.72 | 1 |
| 99 | 0.99-1.70 | 1 |
| 100 | 08.00-20,30 | 1 |
| 101 | 0·0141 | 1 |
| 102 | 1,296/6,758 | 1 |
| 103 | 1,3,4-thiadiazolyl- | 1 |
| 104 | 1-1.4 | 1 |
| 105 | 1.006-1.434 | 1 |
| 106 | 1.080-1.670 | 1 |
| 107 | 1.083-3.027 | 1 |
| 108 | 1.15-1.5 | 1 |
| 109 | 1.223,1.054-1.418 | 1 |
| 110 | 1.24-2.31 | 1 |
| 111 | 1.25-1.54 | 1 |
| 112 | 1.39±.79w/kg | 1 |
| 113 | 1.75-3.05 | 1 |
| 114 | 10.1002/wcs.1324 | 1 |
| 115 | 10.73±1.4 | 1 |
| 116 | 10/8 | 1 |
| 117 | 100/91.7 | 1 |
| 118 | 10mg/daily | 1 |
| 119 | 11.24±1.9 | 1 |
| 120 | 11.9-18.0 | 1 |
| 121 | 11/118 | 1 |
| 122 | 11/4 | 1 |
| 123 | 110/606 | 1 |
| 124 | 115±26 | 1 |
| 125 | 11v | 1 |
| 126 | 12.3-18.7 | 1 |
| 127 | 12/ne/0385 | 1 |
| 128 | 131,631 | 1 |
| 129 | 14,212 | 1 |
| 130 | 15.4±4.9 | 1 |
| 131 | 150,250 | 1 |
| 132 | 17.85-fold | 1 |
| 133 | 170-210°c | 1 |
| 134 | 18.3±2.2 | 1 |
| 135 | 18.67+/-0.72 | 1 |
| 136 | 190±63.1ng/mlh | 1 |
| 137 | 2,4,6-trifluoro- | 1 |
| 138 | 2.14/wk | 1 |
| 139 | 2.3/100,000 | 1 |
| 140 | 2.5g/cow/day | 1 |
| 141 | 2.6±.8 | 1 |
| 142 | 2.72-4.50 | 1 |
| 143 | 2.81±0.85 | 1 |
| 144 | 2.87±1.40 | 1 |
| 145 | 2.88±0.56 | 1 |
| 146 | 2.8fold | 1 |
| 147 | 2.95±0.09 | 1 |
| 148 | 200bar | 1 |
| 149 | 22.5/2.5/1 | 1 |
| 150 | 22/176 | 1 |
| 151 | 22/79 | 1 |
| 152 | 220-age-rest | 1 |
| 153 | 230/57.5 | 1 |
| 154 | 237.50 | 1 |
| 155 | 24,364 | 1 |
| 156 | 25/1,000 | 1 |
| 157 | 250.40 | 1 |
| 158 | 28,672 | 1 |
| 159 | 29,346 | 1 |
| 160 | 3,4-dihydroxyphenylacetate | 1 |
| 161 | 3-10-fold | 1 |
| 162 | 3-one | 1 |
| 163 | 3.2+/-0.44 | 1 |
| 164 | 3.3g/day | 1 |
| 165 | 3.55-3.68 | 1 |
| 166 | 3.5ng | 1 |
| 167 | 3.89+/-0.26 | 1 |
| 168 | 3.9-4.0 | 1 |
| 169 | 3.90±0.30 | 1 |
| 170 | 33ms | 1 |
| 171 | 3w-45s | 1 |
| 172 | 4,301 | 1 |
| 173 | 4-pic=4-picoline | 1 |
| 174 | 4.245 | 1 |
| 175 | 4.273 | 1 |
| 176 | 4.2±0.9 | 1 |
| 177 | 4.368 | 1 |
| 178 | 4.8±0.6 | 1 |
| 179 | 4.9+/-3.0 | 1 |
| 180 | 4/151 | 1 |
| 181 | 40.7-29.7 | 1 |
| 182 | 400:150:75 | 1 |
| 183 | 408.7→272.0 | 1 |
| 184 | 40±1°c | 1 |
| 185 | 41/1000 | 1 |
| 186 | 42-48°c | 1 |
| 187 | 422.7 | 1 |
| 188 | 443/1100 | 1 |
| 189 | 448/3227 | 1 |
| 190 | 44±7.8 | 1 |
| 191 | 5.6±2.9 | 1 |
| 192 | 5/100,000 | 1 |
| 193 | 500/10 | 1 |
| 194 | 51/119 | 1 |
| 195 | 51/70 | 1 |
| 196 | 55/96 | 1 |
| 197 | 550-685 | 1 |
| 198 | 58-271 | 1 |
| 199 | 582.81 | 1 |
| 200 | 6,482 | 1 |
| 201 | 6.5mg/kg | 1 |
| 202 | 6.67-10.20 | 1 |
| 203 | 60/36 | 1 |
| 204 | 69±22 | 1 |
| 205 | 730-810 | 1 |
| 206 | 773,982 | 1 |
| 207 | 8,011 | 1 |
| 208 | 8,697/33,709 | 1 |
| 209 | 8.27±1.57 | 1 |
| 210 | 80ppb | 1 |
| 211 | 9,981 | 1 |
| 212 | 9-4 | 1 |
| 213 | 9.0mm | 1 |
| 214 | 97/100 | 1 |
| 215 | 98±25 | 1 |
| 216 | aa/gg | 1 |
| 217 | abactal | 1 |
| 218 | acd/t | 1 |
| 219 | across-item | 1 |
| 220 | adjusted-hr | 1 |
| 221 | al-class | 1 |
| 222 | aldol-derived | 1 |
| 223 | alfalastin® | 1 |
| 224 | alk3/alk6 | 1 |
| 225 | all-rac | 1 |
| 226 | alpo₄ | 1 |
| 227 | analysis-adjusted | 1 |
| 228 | anger-induction/pain-induction | 1 |
| 229 | anthracyclines-taxanes | 1 |
| 230 | anticoagulant-experienced | 1 |
| 231 | aor=1.76 | 1 |
| 232 | app-βctf | 1 |
| 233 | arcula | 1 |
| 234 | arg16-arg16 | 1 |
| 235 | at-a/n-invg | 1 |
| 236 | auc=0.596 | 1 |
| 237 | auto=0.19±0.23 | 1 |
| 238 | b=-0.022 | 1 |
| 239 | b=-0.024 | 1 |
| 240 | balchem | 1 |
| 241 | basal/resting | 1 |
| 242 | bauc=68.25 | 1 |
| 243 | becker-balagtas | 1 |
| 244 | beriplex | 1 |
| 245 | bisphenol-a-diglycidyl-dimethacrylate-composite | 1 |
| 246 | box-i | 1 |
| 247 | brl49653 | 1 |
| 248 | brs-αlf | 1 |
| 249 | budhiraja | 1 |
| 250 | c0+500 | 1 |
| 251 | c17:1 | 1 |
| 252 | calorie-adjusted | 1 |
| 253 | came25-1 | 1 |
| 254 | cd3+/cd16+ | 1 |
| 255 | cefalu | 1 |
| 256 | cerus | 1 |
| 257 | cgi-i=1 | 1 |
| 258 | cgl2 | 1 |
| 259 | cgp-60536 | 1 |
| 260 | chi2=29.88 | 1 |
| 261 | chuabo | 1 |
| 262 | ciechanowski | 1 |
| 263 | cirb | 1 |
| 264 | cis-enedials | 1 |
| 265 | city-block | 1 |
| 266 | claeson-dahl | 1 |
| 267 | clox-1 | 1 |
| 268 | cluster-wise | 1 |
| 269 | cm1-cm2-cm3 | 1 |
| 270 | cnox | 1 |
| 271 | colorect | 1 |
| 272 | conor | 1 |
| 273 | cortico-striato-gpe | 1 |
| 274 | crystalloid/12 | 1 |
| 275 | cvisept | 1 |
| 276 | cyp2d6*1 | 1 |
| 277 | d172a | 1 |
| 278 | d=-3.52 | 1 |
| 279 | day∗energy∗incongruent/congruent-interaction | 1 |
| 280 | ddd-60 | 1 |
| 281 | deacetylmoxisylyte | 1 |
| 282 | death/hospitalisation | 1 |
| 283 | demographics-adjusted | 1 |
| 284 | departmental-specific | 1 |
| 285 | depressi* | 1 |
| 286 | dibianco | 1 |
| 287 | diiodohydroxyquin | 1 |
| 288 | dioxaphosphepine | 1 |
| 289 | direct/adjusted | 1 |
| 290 | disc* | 1 |
| 291 | dispositif | 1 |
| 292 | drug-eluting-stents | 1 |
| 293 | dvt-to-vein | 1 |
| 294 | efavirenz-efv- | 1 |
| 295 | elastocaloric | 1 |
| 296 | electron-volt | 1 |
| 297 | elfra-1 | 1 |
| 298 | elkjær | 1 |
| 299 | energy/vitamins | 1 |
| 300 | erk=jnk | 1 |
| 301 | eud=91gy | 1 |
| 302 | euro/quality-adjusted | 1 |
| 303 | euro176 | 1 |
| 304 | exercis* | 1 |
| 305 | exploration-based | 1 |
| 306 | exxon | 1 |
| 307 | flumel | 1 |
| 308 | folding-misfolding-refolding | 1 |
| 309 | fs-np-a50 | 1 |
| 310 | g=.35 | 1 |
| 311 | ga/gg | 1 |
| 312 | gal3st2 | 1 |
| 313 | gd→c | 1 |
| 314 | ge-n | 1 |
| 315 | gm-cs | 1 |
| 316 | gmfad7-1/gmfad7-2 | 1 |
| 317 | green-cheeked | 1 |
| 318 | ground-pelleted | 1 |
| 319 | gwet | 1 |
| 320 | ha-hs | 1 |
| 321 | ha-ls | 1 |
| 322 | haematology/biochemistry | 1 |
| 323 | hanhsd | 1 |
| 324 | hbsag-adjusted | 1 |
| 325 | hemoglobinss | 1 |
| 326 | hh1 | 1 |
| 327 | hiskey | 1 |
| 328 | hla-disparate | 1 |
| 329 | hmp35c | 1 |
| 330 | homeopath* | 1 |
| 331 | hpdt | 1 |
| 332 | hprod=above | 1 |
| 333 | hr=2.24 | 1 |
| 334 | hr=5.5 | 1 |
| 335 | hsba-mena | 1 |
| 336 | humid* | 1 |
| 337 | iitc | 1 |
| 338 | il3-rα | 1 |
| 339 | imbizas | 1 |
| 340 | immunotherap* | 1 |
| 341 | infection-dic-1 | 1 |
| 342 | infection-dic-2 | 1 |
| 343 | instrumentarium | 1 |
| 344 | ipi=1 | 1 |
| 345 | isomaltoheptaose | 1 |
| 346 | kaladana | 1 |
| 347 | kensey-nash | 1 |
| 348 | kinnikinnick | 1 |
| 349 | korsakoff* | 1 |
| 350 | kst4d | 1 |
| 351 | l-alanine-based | 1 |
| 352 | l-glutamine-based | 1 |
| 353 | laminectomy/fusion | 1 |
| 354 | lauc=80 | 1 |
| 355 | lbnp-induced | 1 |
| 356 | life-habits | 1 |
| 357 | likuni | 1 |
| 358 | lithium* | 1 |
| 359 | lprod=below | 1 |
| 360 | lv9 | 1 |
| 361 | m=mo | 1 |
| 362 | mac-elisa | 1 |
| 363 | macrodose | 1 |
| 364 | mannkind | 1 |
| 365 | max-rescaled | 1 |
| 366 | meril | 1 |
| 367 | michaelmas | 1 |
| 368 | mild-exercise | 1 |
| 369 | modular- | 1 |
| 370 | moisture-mediated | 1 |
| 371 | most-times | 1 |
| 372 | multi-unit | 1 |
| 373 | multivariale-adjusted | 1 |
| 374 | mumol/l/mg/kg/day | 1 |
| 375 | n-c14 | 1 |
| 376 | n-isopropylacrylamide-co-propylacrylic | 1 |
| 377 | n-octylamine | 1 |
| 378 | n-of-1s | 1 |
| 379 | nct00402506 | 1 |
| 380 | nebuli* | 1 |
| 381 | nnh=15 | 1 |
| 382 | nonequal | 1 |
| 383 | nonevent | 1 |
| 384 | nwp06/placebo | 1 |
| 385 | oculo-vestibular-recoupled | 1 |
| 386 | odiv2.1a | 1 |
| 387 | oligo-nucleotide | 1 |
| 388 | omp25 | 1 |
| 389 | one-day-workshop | 1 |
| 390 | one-serving | 1 |
| 391 | one-wayanova | 1 |
| 392 | oxygen* | 1 |
| 393 | oxygen-inhaling | 1 |
| 394 | p=0.0024/p=0.010 | 1 |
| 395 | p=0.2582 | 1 |
| 396 | p=0.2836 | 1 |
| 397 | p=0.376 | 1 |
| 398 | p=0.5924 | 1 |
| 399 | p=0.781 | 1 |
| 400 | p=0·0153 | 1 |
| 401 | p=0·0398 | 1 |
| 402 | p=0·2081 | 1 |
| 403 | pack-years-adjusted | 1 |
| 404 | pantai | 1 |
| 405 | parameterizing | 1 |
| 406 | paraprofessional* | 1 |
| 407 | patient-companion | 1 |
| 408 | per-decade | 1 |
| 409 | per-minor-allele | 1 |
| 410 | per-organ | 1 |
| 411 | pgr-rich | 1 |
| 412 | phaii | 1 |
| 413 | pinteraction=0.007/0.014 | 1 |
| 414 | pl-class | 1 |
| 415 | placebo-oxytocin | 1 |
| 416 | pm/im | 1 |
| 417 | pnon-inferio | 1 |
| 418 | po/co | 1 |
| 419 | poleo-spearmint | 1 |
| 420 | ponso | 1 |
| 421 | precolonized | 1 |
| 422 | prognosis-adjusted | 1 |
| 423 | propensity-score-adjusted | 1 |
| 424 | pyridin-4 | 1 |
| 425 | p≤.015 | 1 |
| 426 | p≥.13 | 1 |
| 427 | p≥0.19 | 1 |
| 428 | q1=2.92 | 1 |
| 429 | q1=60.1 | 1 |
| 430 | quantisorb | 1 |
| 431 | query-infected | 1 |
| 432 | quinine-pyrimethamine-sulfadiazine | 1 |
| 433 | r517h | 1 |
| 434 | r96.0 | 1 |
| 435 | r=0.191 | 1 |
| 436 | r=0.73-0.76 | 1 |
| 437 | range=20.0-23.4 | 1 |
| 438 | rank-sums | 1 |
| 439 | rasa-sindoor | 1 |
| 440 | rationale-only | 1 |
| 441 | rauc=36.88 | 1 |
| 442 | rauisuchus | 1 |
| 443 | respec | 1 |
| 444 | responder-only | 1 |
| 445 | return-to-dialysis | 1 |
| 446 | rh-alloimmunization | 1 |
| 447 | rhin* | 1 |
| 448 | risperdal® | 1 |
| 449 | rrr=1.66 | 1 |
| 450 | rrr=1.74 | 1 |
| 451 | rrr=6.95 | 1 |
| 452 | running- | 1 |
| 453 | s-protein-based | 1 |
| 454 | s/g2-m | 1 |
| 455 | sds=adjusted | 1 |
| 456 | searchlight™ | 1 |
| 457 | secondary-center | 1 |
| 458 | sesta | 1 |
| 459 | sga-b | 1 |
| 460 | simi'õ | 1 |
| 461 | simulab | 1 |
| 462 | smr=100 | 1 |
| 463 | spoth | 1 |
| 464 | srp/cur | 1 |
| 465 | streptococc* | 1 |
| 466 | stress-augmented | 1 |
| 467 | stretch/shortening | 1 |
| 468 | suavissimoside | 1 |
| 469 | susskind | 1 |
| 470 | sutras | 1 |
| 471 | svegfr1 | 1 |
| 472 | synergy1® | 1 |
| 473 | t-18:1n-7 | 1 |
| 474 | tcr/peptide-mhc | 1 |
| 475 | thiamin* | 1 |
| 476 | tid-qam | 1 |
| 477 | tn/hs | 1 |
| 478 | tokotsubo | 1 |
| 479 | transmedical | 1 |
| 480 | trial-adjusted | 1 |
| 481 | true-to-observed | 1 |
| 482 | txbm | 1 |
| 483 | typhirapid | 1 |
| 484 | undermonitoring | 1 |
| 485 | vein-to-muscle | 1 |
| 486 | veneration | 1 |
| 487 | verapamil/trandolapril/hydrochlorothiazide | 1 |
| 488 | viasys | 1 |
| 489 | vitium | 1 |
| 490 | vpmsmrgg | 1 |
| 491 | vs.38 | 1 |
| 492 | vt+vf+sudden | 1 |
| 493 | w-i/ | 1 |
| 494 | x1x2 | 1 |
| 495 | yavari | 1 |
| 496 | y≤2.0 | 1 |
| 497 | z=6.05 | 1 |
| 498 | £70.66 | 1 |
| 499 | «criteria | 1 |
| 500 | δ12.3 | 1 |
| 501 | δcp/δg | 1 |
| 502 | δpinp | 1 |
| 503 | ν11+ν12 | 1 |
| 504 | €77,832 | 1 |
| 505 | ∆lvesv | 1 |
| 506 | ≥88cm | 1 |
| 1 | 'needs | 1 |
| 2 | 'self-efficacy | 1 |
| 3 | 'validity | 1 |
| 4 | +0.045 | 1 |
| 5 | +1.1/minute | 1 |
| 6 | -0.00094 | 1 |
| 7 | -1.8ml/min | 1 |
| 8 | -13.85 | 1 |
| 9 | -2-0 | 1 |
| 10 | -23.9±4.7 | 1 |
| 11 | -29.3±2.7 | 1 |
| 12 | -777.57 | 1 |
| 13 | -adjusted | 6 |
| 14 | .66±.60w/kg | 1 |
| 15 | //www.annualreviews.org/catalog/pubdates.aspx | 1 |
| 16 | //www.cochrane.org | 1 |
| 17 | //www.cochrane.org/ | 1 |
| 18 | 0-5-point | 1 |
| 19 | 0-iic | 1 |
| 20 | 0.1055 | 1 |
| 21 | 0.5-year | 1 |
| 22 | 0.87±1.21 | 1 |
| 23 | 0.94±1.72 | 1 |
| 24 | 0.99-1.70 | 1 |
| 25 | 08.00-20,30 | 1 |
| 26 | 0·0141 | 1 |
| 27 | 1,296/6,758 | 1 |
| 28 | 1,3,4-thiadiazolyl- | 1 |
| 29 | 1-1.4 | 1 |
| 30 | 1.006-1.434 | 1 |
| 31 | 1.080-1.670 | 1 |
| 32 | 1.083-3.027 | 1 |
| 33 | 1.15-1.5 | 1 |
| 34 | 1.223,1.054-1.418 | 1 |
| 35 | 1.24-2.31 | 1 |
| 36 | 1.25-1.54 | 1 |
| 37 | 1.39±.79w/kg | 1 |
| 38 | 1.75-3.05 | 1 |
| 39 | 1.865 | 2 |
| 40 | 1/year | 2 |
| 41 | 10.1002/wcs.1324 | 1 |
| 42 | 10.73±1.4 | 1 |
| 43 | 10/8 | 1 |
| 44 | 100/90.9 | 2 |
| 45 | 100/91.7 | 1 |
| 46 | 100mg/animal | 2 |
| 47 | 10= | 4 |
| 48 | 10mg/daily | 1 |
| 49 | 11.24±1.9 | 1 |
| 50 | 11.9-18.0 | 1 |
| 51 | 11/118 | 1 |
| 52 | 11/4 | 1 |
| 53 | 110/606 | 1 |
| 54 | 115±26 | 1 |
| 55 | 11v | 1 |
| 56 | 12.3-18.7 | 1 |
| 57 | 12/ne/0385 | 1 |
| 58 | 131,631 | 1 |
| 59 | 14,212 | 1 |
| 60 | 15.4±4.9 | 1 |
| 61 | 150,250 | 1 |
| 62 | 17.85-fold | 1 |
| 63 | 170-210°c | 1 |
| 64 | 18.3±2.2 | 1 |
| 65 | 18.67+/-0.72 | 1 |
| 66 | 190±63.1ng/mlh | 1 |
| 67 | 1mg/kg/hn/saline | 2 |
| 68 | 2,4,6-trifluoro- | 1 |
| 69 | 2.14/wk | 1 |
| 70 | 2.3/100,000 | 1 |
| 71 | 2.5g/cow/day | 1 |
| 72 | 2.6±.8 | 1 |
| 73 | 2.72-4.50 | 1 |
| 74 | 2.81±0.85 | 1 |
| 75 | 2.87±1.40 | 1 |
| 76 | 2.88±0.56 | 1 |
| 77 | 2.8fold | 1 |
| 78 | 2.95±0.09 | 1 |
| 79 | 200bar | 1 |
| 80 | 22,937 | 2 |
| 81 | 22.5/2.5/1 | 1 |
| 82 | 22/176 | 1 |
| 83 | 22/79 | 1 |
| 84 | 220-age-rest | 1 |
| 85 | 230/57.5 | 1 |
| 86 | 237.50 | 1 |
| 87 | 24,364 | 1 |
| 88 | 24hr-1 | 3 |
| 89 | 25/1,000 | 1 |
| 90 | 250.40 | 1 |
| 91 | 28,672 | 1 |
| 92 | 29,346 | 1 |
| 93 | 3,4-dihydroxyphenylacetate | 1 |
| 94 | 3-10-fold | 1 |
| 95 | 3-one | 1 |
| 96 | 3.2+/-0.44 | 1 |
| 97 | 3.3g/day | 1 |
| 98 | 3.55-3.68 | 1 |
| 99 | 3.5ng | 1 |
| 100 | 3.89+/-0.26 | 1 |
| 101 | 3.9-4.0 | 1 |
| 102 | 3.90±0.30 | 1 |
| 103 | 33ms | 1 |
| 104 | 3w-45s | 1 |
| 105 | 4,301 | 1 |
| 106 | 4-pic=4-picoline | 1 |
| 107 | 4.245 | 1 |
| 108 | 4.273 | 1 |
| 109 | 4.2±0.9 | 1 |
| 110 | 4.368 | 1 |
| 111 | 4.8±0.6 | 1 |
| 112 | 4.9+/-3.0 | 1 |
| 113 | 4/151 | 1 |
| 114 | 40.7-29.7 | 1 |
| 115 | 400:150:75 | 1 |
| 116 | 408.7→272.0 | 1 |
| 117 | 40±1°c | 1 |
| 118 | 41/1000 | 1 |
| 119 | 42-48°c | 1 |
| 120 | 422.7 | 1 |
| 121 | 42°c±0.5°c | 2 |
| 122 | 443/1100 | 1 |
| 123 | 448/3227 | 1 |
| 124 | 44±7.8 | 1 |
| 125 | 5.0/1000 | 2 |
| 126 | 5.6±2.9 | 1 |
| 127 | 5/100,000 | 1 |
| 128 | 500/10 | 1 |
| 129 | 51/119 | 1 |
| 130 | 51/70 | 1 |
| 131 | 52.8°c | 2 |
| 132 | 55/96 | 1 |
| 133 | 550-685 | 1 |
| 134 | 58-271 | 1 |
| 135 | 582.81 | 1 |
| 136 | 6,482 | 1 |
| 137 | 6.5mg/kg | 1 |
| 138 | 6.67-10.20 | 1 |
| 139 | 60/36 | 1 |
| 140 | 69±22 | 1 |
| 141 | 730-810 | 1 |
| 142 | 773,982 | 1 |
| 143 | 8,011 | 1 |
| 144 | 8,697/33,709 | 1 |
| 145 | 8.27±1.57 | 1 |
| 146 | 80ppb | 1 |
| 147 | 9,981 | 1 |
| 148 | 9-4 | 1 |
| 149 | 9.0mm | 1 |
| 150 | 97/100 | 1 |
| 151 | 98±25 | 1 |
| 152 | aa/gg | 1 |
| 153 | abactal | 1 |
| 154 | acd/t | 1 |
| 155 | across-item | 1 |
| 156 | adjusted | 12,840 |
| 157 | adjusted-hr | 1 |
| 158 | al-class | 1 |
| 159 | aldol-derived | 1 |
| 160 | alfalastin® | 1 |
| 161 | alk3/alk6 | 1 |
| 162 | all-rac | 1 |
| 163 | alpo₄ | 1 |
| 164 | analysis-adjusted | 1 |
| 165 | anger-induction/pain-induction | 1 |
| 166 | anthracyclines-taxanes | 1 |
| 167 | anticoagulant-experienced | 1 |
| 168 | antirenin | 2 |
| 169 | aor=1.76 | 1 |
| 170 | app-βctf | 1 |
| 171 | arcula | 1 |
| 172 | arg16-arg16 | 1 |
| 173 | at-a/n-invg | 1 |
| 174 | atom-based | 5 |
| 175 | auc=0.596 | 1 |
| 176 | auto=0.19±0.23 | 1 |
| 177 | b=-0.022 | 1 |
| 178 | b=-0.024 | 1 |
| 179 | balchem | 1 |
| 180 | basal/resting | 1 |
| 181 | bauc=68.25 | 1 |
| 182 | becker-balagtas | 1 |
| 183 | beriplex | 1 |
| 184 | between-components | 2 |
| 185 | bisphenol-a-diglycidyl-dimethacrylate-composite | 1 |
| 186 | box-i | 1 |
| 187 | brl49653 | 1 |
| 188 | brs-αlf | 1 |
| 189 | budhiraja | 1 |
| 190 | c0+500 | 1 |
| 191 | c17:1 | 1 |
| 192 | calorie-adjusted | 1 |
| 193 | came25-1 | 1 |
| 194 | carafate | 2 |
| 195 | cd3+/cd16+ | 1 |
| 196 | cefalu | 1 |
| 197 | cerus | 1 |
| 198 | cgi-i=1 | 1 |
| 199 | cgl2 | 1 |
| 200 | cgp-60536 | 1 |
| 201 | chi2=29.88 | 1 |
| 202 | chuabo | 1 |
| 203 | ciechanowski | 1 |
| 204 | cirb | 1 |
| 205 | cis-enedials | 1 |
| 206 | city-block | 1 |
| 207 | claeson-dahl | 1 |
| 208 | clox-1 | 1 |
| 209 | cluster-adjusted | 24 |
| 210 | cluster-wise | 1 |
| 211 | cm1-cm2-cm3 | 1 |
| 212 | cnox | 1 |
| 213 | collected.the | 3 |
| 214 | colorect | 1 |
| 215 | confounder-adjusted | 5 |
| 216 | conor | 1 |
| 217 | constant- | 2 |
| 218 | corixa | 2 |
| 219 | cortico-striato-gpe | 1 |
| 220 | crystalloid/12 | 1 |
| 221 | cvisept | 1 |
| 222 | cyp2d6*1 | 1 |
| 223 | d172a | 1 |
| 224 | d=-3.52 | 1 |
| 225 | day∗energy∗incongruent/congruent-interaction | 1 |
| 226 | ddd-60 | 1 |
| 227 | deacetylmoxisylyte | 1 |
| 228 | death/hospitalisation | 1 |
| 229 | demographics-adjusted | 1 |
| 230 | departmental-specific | 1 |
| 231 | depressi* | 1 |
| 232 | dibianco | 1 |
| 233 | diiodohydroxyquin | 1 |
| 234 | dioxaphosphepine | 1 |
| 235 | direct/adjusted | 1 |
| 236 | disc* | 1 |
| 237 | dispositif | 1 |
| 238 | drug-eluting-stents | 1 |
| 239 | dvt-to-vein | 1 |
| 240 | e-flip | 2 |
| 241 | ear-based | 2 |
| 242 | efavirenz-efv- | 1 |
| 243 | elastocaloric | 1 |
| 244 | electron-volt | 1 |
| 245 | elfra-1 | 1 |
| 246 | elkjær | 1 |
| 247 | end-of-period | 2 |
| 248 | energy/vitamins | 1 |
| 249 | eou | 3 |
| 250 | erbe | 6 |
| 251 | erk=jnk | 1 |
| 252 | eud=91gy | 1 |
| 253 | euro/quality-adjusted | 1 |
| 254 | euro176 | 1 |
| 255 | exercis* | 1 |
| 256 | exploration-based | 1 |
| 257 | exxon | 1 |
| 258 | flumel | 1 |
| 259 | folding-misfolding-refolding | 1 |
| 260 | framingham- | 2 |
| 261 | frequency*severity | 2 |
| 262 | fs-np-a50 | 1 |
| 263 | g=.35 | 1 |
| 264 | ga/gg | 1 |
| 265 | gal3st2 | 1 |
| 266 | gammagard | 2 |
| 267 | gd→c | 1 |
| 268 | ge-n | 1 |
| 269 | gm-cs | 1 |
| 270 | gmfad7-1/gmfad7-2 | 1 |
| 271 | graft-level | 5 |
| 272 | green-cheeked | 1 |
| 273 | ground-pelleted | 1 |
| 274 | gwet | 1 |
| 275 | ha-hs | 1 |
| 276 | ha-ls | 1 |
| 277 | hadji | 2 |
| 278 | haematology/biochemistry | 1 |
| 279 | hanhsd | 1 |
| 280 | hbiii | 2 |
| 281 | hbsag-adjusted | 1 |
| 282 | hemoglobinss | 1 |
| 283 | hh1 | 1 |
| 284 | hh₃ | 5 |
| 285 | hiskey | 1 |
| 286 | hla-disparate | 1 |
| 287 | hmp35c | 1 |
| 288 | ho2c-peg600-dtcz | 3 |
| 289 | homeopath* | 1 |
| 290 | hpdt | 1 |
| 291 | hprod=above | 1 |
| 292 | hr=2.24 | 1 |
| 293 | hr=5.5 | 1 |
| 294 | hsba-mena | 1 |
| 295 | humid* | 1 |
| 296 | iitc | 1 |
| 297 | il3-rα | 1 |
| 298 | imbizas | 1 |
| 299 | immunotherap* | 1 |
| 300 | infection-dic-1 | 1 |
| 301 | infection-dic-2 | 1 |
| 302 | instrumentarium | 1 |
| 303 | insulet | 2 |
| 304 | interview* | 2 |
| 305 | ipi=1 | 1 |
| 306 | isomaltoheptaose | 1 |
| 307 | jewett | 6 |
| 308 | k-m | 9 |
| 309 | kaladana | 1 |
| 310 | kensey-nash | 1 |
| 311 | kiddie-schedule | 2 |
| 312 | kinnikinnick | 1 |
| 313 | korsakoff* | 1 |
| 314 | kst4d | 1 |
| 315 | l-alanine-based | 1 |
| 316 | l-glutamine-based | 1 |
| 317 | laminectomy/fusion | 1 |
| 318 | lauc=80 | 1 |
| 319 | lbnp-induced | 1 |
| 320 | lecg | 2 |
| 321 | lesion-to-pancreas | 2 |
| 322 | life-habits | 1 |
| 323 | likuni | 1 |
| 324 | lithium* | 1 |
| 325 | lprod=below | 1 |
| 326 | lv9 | 1 |
| 327 | m=mo | 1 |
| 328 | mac-elisa | 1 |
| 329 | macrodose | 1 |
| 330 | mannkind | 1 |
| 331 | max-rescaled | 1 |
| 332 | mccall | 2 |
| 333 | meril | 1 |
| 334 | mersilene™ | 2 |
| 335 | mic50/90 | 3 |
| 336 | michaelmas | 1 |
| 337 | mild-exercise | 1 |
| 338 | model-adjusted | 14 |
| 339 | model-generalized | 2 |
| 340 | modular- | 1 |
| 341 | moisture-mediated | 1 |
| 342 | most-diseased-segment | 2 |
| 343 | most-times | 1 |
| 344 | multi-unit | 1 |
| 345 | multiple-adjusted | 7 |
| 346 | multivariable-adjusted | 136 |
| 347 | multivariale-adjusted | 1 |
| 348 | multivariate-adjusted | 81 |
| 349 | mumol/l/mg/kg/day | 1 |
| 350 | n-c14 | 1 |
| 351 | n-isopropylacrylamide-co-propylacrylic | 1 |
| 352 | n-octylamine | 1 |
| 353 | n-of-1s | 1 |
| 354 | nct00402506 | 1 |
| 355 | near-stasis | 2 |
| 356 | nebuli* | 1 |
| 357 | nitta | 2 |
| 358 | nnh=15 | 1 |
| 359 | nonequal | 1 |
| 360 | nonevent | 1 |
| 361 | nwp06/placebo | 1 |
| 362 | oculo-vestibular-recoupled | 1 |
| 363 | odiv2.1a | 1 |
| 364 | oligo-nucleotide | 1 |
| 365 | omp25 | 1 |
| 366 | one-day-workshop | 1 |
| 367 | one-serving | 1 |
| 368 | one-wayanova | 1 |
| 369 | oxygen* | 1 |
| 370 | oxygen-inhaling | 1 |
| 371 | p=0.0024/p=0.010 | 1 |
| 372 | p=0.2582 | 1 |
| 373 | p=0.2836 | 1 |
| 374 | p=0.376 | 1 |
| 375 | p=0.5924 | 1 |
| 376 | p=0.781 | 1 |
| 377 | p=0·0153 | 1 |
| 378 | p=0·0398 | 1 |
| 379 | p=0·2081 | 1 |
| 380 | pack-years-adjusted | 1 |
| 381 | pantai | 1 |
| 382 | parameterizing | 1 |
| 383 | paraprofessional* | 1 |
| 384 | patient-companion | 1 |
| 385 | per-allele | 18 |
| 386 | per-decade | 1 |
| 387 | per-minor-allele | 1 |
| 388 | per-organ | 1 |
| 389 | peto | 802 |
| 390 | pgr-poor | 2 |
| 391 | pgr-rich | 1 |
| 392 | phaii | 1 |
| 393 | pinteraction=0.007/0.014 | 1 |
| 394 | pl-class | 1 |
| 395 | placebo-oxytocin | 1 |
| 396 | pm/im | 1 |
| 397 | pnon-inferio | 1 |
| 398 | po/co | 1 |
| 399 | poleo-spearmint | 1 |
| 400 | pondered | 2 |
| 401 | ponso | 1 |
| 402 | post15 | 4 |
| 403 | precolonized | 1 |
| 404 | prognosis-adjusted | 1 |
| 405 | propensity-score-adjusted | 1 |
| 406 | pyridin-4 | 1 |
| 407 | p≤.015 | 1 |
| 408 | p≥.13 | 1 |
| 409 | p≥0.19 | 1 |
| 410 | q1=2.92 | 1 |
| 411 | q1=60.1 | 1 |
| 412 | quantisorb | 1 |
| 413 | query-infected | 1 |
| 414 | quinine-pyrimethamine-sulfadiazine | 1 |
| 415 | r517h | 1 |
| 416 | r96.0 | 1 |
| 417 | r=0.191 | 1 |
| 418 | r=0.73-0.76 | 1 |
| 419 | range=20.0-23.4 | 1 |
| 420 | rank-sums | 1 |
| 421 | rasa-sindoor | 1 |
| 422 | rationale-only | 1 |
| 423 | rauc=36.88 | 1 |
| 424 | rauisuchus | 1 |
| 425 | re=eu | 4 |
| 426 | rem3 | 2 |
| 427 | respec | 1 |
| 428 | responder-only | 1 |
| 429 | resynchronization/defibrillation | 2 |
| 430 | return-to-dialysis | 1 |
| 431 | rh-alloimmunization | 1 |
| 432 | rhin* | 1 |
| 433 | risperdal® | 1 |
| 434 | rrr=1.66 | 1 |
| 435 | rrr=1.74 | 1 |
| 436 | rrr=6.95 | 1 |
| 437 | running- | 1 |
| 438 | s-protein-based | 1 |
| 439 | s/g2-m | 1 |
| 440 | score- | 4 |
| 441 | score-adjusted | 34 |
| 442 | sds=adjusted | 1 |
| 443 | searchlight™ | 1 |
| 444 | secondary-center | 1 |
| 445 | sesta | 1 |
| 446 | sga-b | 1 |
| 447 | shiken | 2 |
| 448 | simi'õ | 1 |
| 449 | simulab | 1 |
| 450 | single-decrement | 2 |
| 451 | smr=100 | 1 |
| 452 | spoth | 1 |
| 453 | srp/cur | 1 |
| 454 | streptococc* | 1 |
| 455 | stress-augmented | 1 |
| 456 | stretch/shortening | 1 |
| 457 | suavissimoside | 1 |
| 458 | sur1 | 3 |
| 459 | susskind | 1 |
| 460 | sutras | 1 |
| 461 | svegfr1 | 1 |
| 462 | synergy1® | 1 |
| 463 | t-18:1n-7 | 1 |
| 464 | tcr/peptide-mhc | 1 |
| 465 | thiamin* | 1 |
| 466 | tid-qam | 1 |
| 467 | tiselius | 3 |
| 468 | tn/hs | 1 |
| 469 | tokotsubo | 1 |
| 470 | top-decile | 4 |
| 471 | transmedical | 1 |
| 472 | trial-adjusted | 1 |
| 473 | true-to-observed | 1 |
| 474 | txbm | 1 |
| 475 | typhirapid | 1 |
| 476 | ugeskrift | 2 |
| 477 | uhn | 6 |
| 478 | unadjusted | 1,115 |
| 479 | undermonitoring | 1 |
| 480 | utw | 2 |
| 481 | vein-to-muscle | 1 |
| 482 | veneration | 1 |
| 483 | verapamil/trandolapril/hydrochlorothiazide | 1 |
| 484 | viasys | 1 |
| 485 | vitium | 1 |
| 486 | vpmsmrgg | 1 |
| 487 | vs.38 | 1 |
| 488 | vt+vf+sudden | 1 |
| 489 | w-i/ | 1 |
| 490 | x1x2 | 1 |
| 491 | yavari | 1 |
| 492 | yousilin | 8 |
| 493 | y≤2.0 | 1 |
| 494 | z=6.05 | 1 |
| 495 | £70.66 | 1 |
| 496 | «criteria | 1 |
| 497 | β=0.005 | 3 |
| 498 | δ12.3 | 1 |
| 499 | δbsg=3 | 2 |
| 500 | δcp/δg | 1 |
| 501 | δpinp | 1 |
| 502 | ν11+ν12 | 1 |
| 503 | €77,832 | 1 |
| 504 | ∆lvesv | 1 |
| 505 | −0.33 | 2 |
| 506 | ≥88cm | 1 |
| 1 | streptococc* | 1 |
| 2 | disc* | 1 |
| 3 | humid* | 1 |
| 4 | korsakoff* | 1 |
| 5 | homeopath* | 1 |
| 6 | nebuli* | 1 |
| 7 | depressi* | 1 |
| 8 | paraprofessional* | 1 |
| 9 | lithium* | 1 |
| 10 | oxygen* | 1 |
| 11 | rhin* | 1 |
| 12 | thiamin* | 1 |
| 13 | immunotherap* | 1 |
| 14 | exercis* | 1 |
| 15 | interview* | 2 |
| 16 | cd3+/cd16+ | 1 |
| 17 | score- | 4 |
| 18 | running- | 1 |
| 19 | 1,3,4-thiadiazolyl- | 1 |
| 20 | framingham- | 2 |
| 21 | 2,4,6-trifluoro- | 1 |
| 22 | modular- | 1 |
| 23 | constant- | 2 |
| 24 | efavirenz-efv- | 1 |
| 25 | //www.cochrane.org/ | 1 |
| 26 | w-i/ | 1 |
| 27 | -2-0 | 1 |
| 28 | 408.7→272.0 | 1 |
| 29 | y≤2.0 | 1 |
| 30 | 4.9+/-3.0 | 1 |
| 31 | 3.9-4.0 | 1 |
| 32 | r96.0 | 1 |
| 33 | 11.9-18.0 | 1 |
| 34 | 2.3/100,000 | 1 |
| 35 | 5/100,000 | 1 |
| 36 | 25/1,000 | 1 |
| 37 | 5.0/1000 | 2 |
| 38 | 41/1000 | 1 |
| 39 | 97/100 | 1 |
| 40 | 443/1100 | 1 |
| 41 | smr=100 | 1 |
| 42 | c0+500 | 1 |
| 43 | 500/10 | 1 |
| 44 | p=0.0024/p=0.010 | 1 |
| 45 | 730-810 | 1 |
| 46 | 6.67-10.20 | 1 |
| 47 | 08.00-20,30 | 1 |
| 48 | 3.90±0.30 | 1 |
| 49 | 250.40 | 1 |
| 50 | 2.87±1.40 | 1 |
| 51 | 2.72-4.50 | 1 |
| 52 | 237.50 | 1 |
| 53 | 150,250 | 1 |
| 54 | fs-np-a50 | 1 |
| 55 | ddd-60 | 1 |
| 56 | 0.99-1.70 | 1 |
| 57 | 51/70 | 1 |
| 58 | 1.080-1.670 | 1 |
| 59 | lauc=80 | 1 |
| 60 | mic50/90 | 3 |
| 61 | cyp2d6*1 | 1 |
| 62 | came25-1 | 1 |
| 63 | elfra-1 | 1 |
| 64 | infection-dic-1 | 1 |
| 65 | 24hr-1 | 3 |
| 66 | clox-1 | 1 |
| 67 | q1=60.1 | 1 |
| 68 | 22.5/2.5/1 | 1 |
| 69 | 4,301 | 1 |
| 70 | 8,011 | 1 |
| 71 | 0.87±1.21 | 1 |
| 72 | 1.24-2.31 | 1 |
| 73 | 131,631 | 1 |
| 74 | 0·0141 | 1 |
| 75 | 4/151 | 1 |
| 76 | 58-271 | 1 |
| 77 | 582.81 | 1 |
| 78 | p=0·2081 | 1 |
| 79 | p=0.781 | 1 |
| 80 | 9,981 | 1 |
| 81 | r=0.191 | 1 |
| 82 | c17:1 | 1 |
| 83 | cgi-i=1 | 1 |
| 84 | ipi=1 | 1 |
| 85 | hh1 | 1 |
| 86 | svegfr1 | 1 |
| 87 | sur1 | 3 |
| 88 | gmfad7-1/gmfad7-2 | 1 |
| 89 | infection-dic-2 | 1 |
| 90 | 18.3±2.2 | 1 |
| 91 | crystalloid/12 | 1 |
| 92 | 14,212 | 1 |
| 93 | ν11+ν12 | 1 |
| 94 | b=-0.022 | 1 |
| 95 | 69±22 | 1 |
| 96 | €77,832 | 1 |
| 97 | d=-3.52 | 1 |
| 98 | 18.67+/-0.72 | 1 |
| 99 | 0.94±1.72 | 1 |
| 100 | 28,672 | 1 |
| 101 | 6,482 | 1 |
| 102 | p=0.2582 | 1 |
| 103 | 773,982 | 1 |
| 104 | q1=2.92 | 1 |
| 105 | cgl2 | 1 |
| 106 | gal3st2 | 1 |
| 107 | x1x2 | 1 |
| 108 | δ12.3 | 1 |
| 109 | p≥.13 | 1 |
| 110 | auto=0.19±0.23 | 1 |
| 111 | −0.33 | 2 |
| 112 | p=0·0153 | 1 |
| 113 | brl49653 | 1 |
| 114 | 4.273 | 1 |
| 115 | δbsg=3 | 2 |
| 116 | cm1-cm2-cm3 | 1 |
| 117 | rem3 | 2 |
| 118 | 9-4 | 1 |
| 119 | pyridin-4 | 1 |
| 120 | 1-1.4 | 1 |
| 121 | 10.73±1.4 | 1 |
| 122 | range=20.0-23.4 | 1 |
| 123 | 11/4 | 1 |
| 124 | pinteraction=0.007/0.014 | 1 |
| 125 | n-c14 | 1 |
| 126 | hr=2.24 | 1 |
| 127 | b=-0.024 | 1 |
| 128 | 10.1002/wcs.1324 | 1 |
| 129 | p=0.5924 | 1 |
| 130 | 1.006-1.434 | 1 |
| 131 | 3.2+/-0.44 | 1 |
| 132 | 1.25-1.54 | 1 |
| 133 | 24,364 | 1 |
| 134 | rrr=1.74 | 1 |
| 135 | -0.00094 | 1 |
| 136 | 1.15-1.5 | 1 |
| 137 | hr=5.5 | 1 |
| 138 | 230/57.5 | 1 |
| 139 | 1.75-3.05 | 1 |
| 140 | z=6.05 | 1 |
| 141 | β=0.005 | 3 |
| 142 | p≤.015 | 1 |
| 143 | nnh=15 | 1 |
| 144 | post15 | 4 |
| 145 | bauc=68.25 | 1 |
| 146 | omp25 | 1 |
| 147 | 98±25 | 1 |
| 148 | g=.35 | 1 |
| 149 | +0.045 | 1 |
| 150 | 4.245 | 1 |
| 151 | 0.1055 | 1 |
| 152 | 1.865 | 2 |
| 153 | 400:150:75 | 1 |
| 154 | 2.81±0.85 | 1 |
| 155 | -13.85 | 1 |
| 156 | 12/ne/0385 | 1 |
| 157 | 550-685 | 1 |
| 158 | rrr=6.95 | 1 |
| 159 | 4.8±0.6 | 1 |
| 160 | nct00402506 | 1 |
| 161 | 110/606 | 1 |
| 162 | arg16-arg16 | 1 |
| 163 | 3.89+/-0.26 | 1 |
| 164 | 115±26 | 1 |
| 165 | 60/36 | 1 |
| 166 | cgp-60536 | 1 |
| 167 | p=0.2836 | 1 |
| 168 | 29,346 | 1 |
| 169 | 2.88±0.56 | 1 |
| 170 | £70.66 | 1 |
| 171 | rrr=1.66 | 1 |
| 172 | r=0.73-0.76 | 1 |
| 173 | aor=1.76 | 1 |
| 174 | 22/176 | 1 |
| 175 | euro176 | 1 |
| 176 | p=0.376 | 1 |
| 177 | 55/96 | 1 |
| 178 | auc=0.596 | 1 |
| 179 | alk3/alk6 | 1 |
| 180 | t-18:1n-7 | 1 |
| 181 | 100/91.7 | 1 |
| 182 | 422.7 | 1 |
| 183 | -29.3±2.7 | 1 |
| 184 | -23.9±4.7 | 1 |
| 185 | 12.3-18.7 | 1 |
| 186 | 40.7-29.7 | 1 |
| 187 | 1.083-3.027 | 1 |
| 188 | 448/3227 | 1 |
| 189 | 22,937 | 2 |
| 190 | 8.27±1.57 | 1 |
| 191 | -777.57 | 1 |
| 192 | 44±7.8 | 1 |
| 193 | 2.6±.8 | 1 |
| 194 | 10/8 | 1 |
| 195 | 11/118 | 1 |
| 196 | 1.223,1.054-1.418 | 1 |
| 197 | vs.38 | 1 |
| 198 | 1,296/6,758 | 1 |
| 199 | 3.55-3.68 | 1 |
| 200 | 4.368 | 1 |
| 201 | rauc=36.88 | 1 |
| 202 | chi2=29.88 | 1 |
| 203 | p=0·0398 | 1 |
| 204 | 100/90.9 | 2 |
| 205 | 4.2±0.9 | 1 |
| 206 | 11.24±1.9 | 1 |
| 207 | 5.6±2.9 | 1 |
| 208 | 15.4±4.9 | 1 |
| 209 | 2.95±0.09 | 1 |
| 210 | 8,697/33,709 | 1 |
| 211 | p≥0.19 | 1 |
| 212 | 51/119 | 1 |
| 213 | 22/79 | 1 |
| 214 | lv9 | 1 |
| 215 | 10= | 4 |
| 216 | odiv2.1a | 1 |
| 217 | d172a | 1 |
| 218 | «criteria | 1 |
| 219 | budhiraja | 1 |
| 220 | arcula | 1 |
| 221 | kaladana | 1 |
| 222 | hsba-mena | 1 |
| 223 | mac-elisa | 1 |
| 224 | sesta | 1 |
| 225 | nitta | 2 |
| 226 | one-wayanova | 1 |
| 227 | corixa | 2 |
| 228 | sga-b | 1 |
| 229 | simulab | 1 |
| 230 | 80ppb | 1 |
| 231 | cirb | 1 |
| 232 | quantisorb | 1 |
| 233 | hmp35c | 1 |
| 234 | all-rac | 1 |
| 235 | respec | 1 |
| 236 | tcr/peptide-mhc | 1 |
| 237 | departmental-specific | 1 |
| 238 | 0-iic | 1 |
| 239 | n-isopropylacrylamide-co-propylacrylic | 1 |
| 240 | elastocaloric | 1 |
| 241 | iitc | 1 |
| 242 | gd→c | 1 |
| 243 | 170-210°c | 1 |
| 244 | 40±1°c | 1 |
| 245 | 42°c±0.5°c | 2 |
| 246 | 52.8°c | 2 |
| 247 | 42-48°c | 1 |
| 248 | kst4d | 1 |
| 249 | anticoagulant-experienced | 1 |
| 250 | lbnp-induced | 1 |
| 251 | green-cheeked | 1 |
| 252 | max-rescaled | 1 |
| 253 | oculo-vestibular-recoupled | 1 |
| 254 | pondered | 2 |
| 255 | l-glutamine-based | 1 |
| 256 | l-alanine-based | 1 |
| 257 | atom-based | 5 |
| 258 | s-protein-based | 1 |
| 259 | exploration-based | 1 |
| 260 | ear-based | 2 |
| 261 | moisture-mediated | 1 |
| 262 | query-infected | 1 |
| 263 | ground-pelleted | 1 |
| 264 | stress-augmented | 1 |
| 265 | adjusted | 12,840 |
| 266 | -adjusted | 6 |
| 267 | calorie-adjusted | 1 |
| 268 | multivariale-adjusted | 1 |
| 269 | multivariable-adjusted | 136 |
| 270 | multiple-adjusted | 7 |
| 271 | score-adjusted | 34 |
| 272 | propensity-score-adjusted | 1 |
| 273 | multivariate-adjusted | 81 |
| 274 | hbsag-adjusted | 1 |
| 275 | trial-adjusted | 1 |
| 276 | model-adjusted | 14 |
| 277 | confounder-adjusted | 5 |
| 278 | cluster-adjusted | 24 |
| 279 | demographics-adjusted | 1 |
| 280 | prognosis-adjusted | 1 |
| 281 | analysis-adjusted | 1 |
| 282 | pack-years-adjusted | 1 |
| 283 | euro/quality-adjusted | 1 |
| 284 | direct/adjusted | 1 |
| 285 | sds=adjusted | 1 |
| 286 | unadjusted | 1,115 |
| 287 | aldol-derived | 1 |
| 288 | true-to-observed | 1 |
| 289 | model-generalized | 2 |
| 290 | precolonized | 1 |
| 291 | typhirapid | 1 |
| 292 | 3-10-fold | 1 |
| 293 | 17.85-fold | 1 |
| 294 | 2.8fold | 1 |
| 295 | mannkind | 1 |
| 296 | susskind | 1 |
| 297 | end-of-period | 2 |
| 298 | gammagard | 2 |
| 299 | hanhsd | 1 |
| 300 | erbe | 6 |
| 301 | per-decade | 1 |
| 302 | suavissimoside | 1 |
| 303 | oligo-nucleotide | 1 |
| 304 | verapamil/trandolapril/hydrochlorothiazide | 1 |
| 305 | collected.the | 3 |
| 306 | vein-to-muscle | 1 |
| 307 | per-allele | 18 |
| 308 | per-minor-allele | 1 |
| 309 | top-decile | 4 |
| 310 | kiddie-schedule | 2 |
| 311 | 1mg/kg/hn/saline | 2 |
| 312 | 4-pic=4-picoline | 1 |
| 313 | n-octylamine | 1 |
| 314 | dioxaphosphepine | 1 |
| 315 | quinine-pyrimethamine-sulfadiazine | 1 |
| 316 | 3-one | 1 |
| 317 | cortico-striato-gpe | 1 |
| 318 | mild-exercise | 1 |
| 319 | cluster-wise | 1 |
| 320 | isomaltoheptaose | 1 |
| 321 | macrodose | 1 |
| 322 | carafate | 2 |
| 323 | hla-disparate | 1 |
| 324 | 3,4-dihydroxyphenylacetate | 1 |
| 325 | bisphenol-a-diglycidyl-dimethacrylate-composite | 1 |
| 326 | +1.1/minute | 1 |
| 327 | deacetylmoxisylyte | 1 |
| 328 | hprod=above | 1 |
| 329 | dispositif | 1 |
| 330 | brs-αlf | 1 |
| 331 | app-βctf | 1 |
| 332 | lecg | 2 |
| 333 | aa/gg | 1 |
| 334 | ga/gg | 1 |
| 335 | vpmsmrgg | 1 |
| 336 | 6.5mg/kg | 1 |
| 337 | .66±.60w/kg | 1 |
| 338 | 1.39±.79w/kg | 1 |
| 339 | 3.5ng | 1 |
| 340 | folding-misfolding-refolding | 1 |
| 341 | oxygen-inhaling | 1 |
| 342 | stretch/shortening | 1 |
| 343 | undermonitoring | 1 |
| 344 | basal/resting | 1 |
| 345 | one-serving | 1 |
| 346 | parameterizing | 1 |
| 347 | //www.cochrane.org | 1 |
| 348 | at-a/n-invg | 1 |
| 349 | δcp/δg | 1 |
| 350 | r517h | 1 |
| 351 | pgr-rich | 1 |
| 352 | 190±63.1ng/mlh | 1 |
| 353 | kensey-nash | 1 |
| 354 | spoth | 1 |
| 355 | box-i | 1 |
| 356 | pantai | 1 |
| 357 | phaii | 1 |
| 358 | hbiii | 2 |
| 359 | hadji | 2 |
| 360 | ciechanowski | 1 |
| 361 | likuni | 1 |
| 362 | yavari | 1 |
| 363 | kinnikinnick | 1 |
| 364 | city-block | 1 |
| 365 | erk=jnk | 1 |
| 366 | 2.14/wk | 1 |
| 367 | transmedical | 1 |
| 368 | 100mg/animal | 2 |
| 369 | abactal | 1 |
| 370 | nonequal | 1 |
| 371 | flumel | 1 |
| 372 | graft-level | 5 |
| 373 | claeson-dahl | 1 |
| 374 | meril | 1 |
| 375 | mccall | 2 |
| 376 | s/g2-m | 1 |
| 377 | k-m | 9 |
| 378 | tid-qam | 1 |
| 379 | txbm | 1 |
| 380 | ≥88cm | 1 |
| 381 | balchem | 1 |
| 382 | across-item | 1 |
| 383 | pm/im | 1 |
| 384 | 9.0mm | 1 |
| 385 | instrumentarium | 1 |
| 386 | vitium | 1 |
| 387 | ge-n | 1 |
| 388 | per-organ | 1 |
| 389 | vt+vf+sudden | 1 |
| 390 | shiken | 2 |
| 391 | uhn | 6 |
| 392 | placebo-oxytocin | 1 |
| 393 | dvt-to-vein | 1 |
| 394 | yousilin | 8 |
| 395 | -1.8ml/min | 1 |
| 396 | antirenin | 2 |
| 397 | diiodohydroxyquin | 1 |
| 398 | patient-companion | 1 |
| 399 | laminectomy/fusion | 1 |
| 400 | resynchronization/defibrillation | 2 |
| 401 | veneration | 1 |
| 402 | death/hospitalisation | 1 |
| 403 | rh-alloimmunization | 1 |
| 404 | day∗energy∗incongruent/congruent-interaction | 1 |
| 405 | anger-induction/pain-induction | 1 |
| 406 | exxon | 1 |
| 407 | chuabo | 1 |
| 408 | nwp06/placebo | 1 |
| 409 | tokotsubo | 1 |
| 410 | po/co | 1 |
| 411 | dibianco | 1 |
| 412 | pnon-inferio | 1 |
| 413 | m=mo | 1 |
| 414 | ponso | 1 |
| 415 | peto | 802 |
| 416 | e-flip | 2 |
| 417 | δpinp | 1 |
| 418 | one-day-workshop | 1 |
| 419 | 200bar | 1 |
| 420 | 0.5-year | 1 |
| 421 | 1/year | 2 |
| 422 | secondary-center | 1 |
| 423 | adjusted-hr | 1 |
| 424 | conor | 1 |
| 425 | rasa-sindoor | 1 |
| 426 | pgr-poor | 2 |
| 427 | srp/cur | 1 |
| 428 | elkjær | 1 |
| 429 | n-of-1s | 1 |
| 430 | 3w-45s | 1 |
| 431 | lesion-to-pancreas | 2 |
| 432 | michaelmas | 1 |
| 433 | sutras | 1 |
| 434 | becker-balagtas | 1 |
| 435 | imbizas | 1 |
| 436 | gm-cs | 1 |
| 437 | 'needs | 1 |
| 438 | most-times | 1 |
| 439 | anthracyclines-taxanes | 1 |
| 440 | ha-hs | 1 |
| 441 | tn/hs | 1 |
| 442 | near-stasis | 2 |
| 443 | return-to-dialysis | 1 |
| 444 | ha-ls | 1 |
| 445 | cis-enedials | 1 |
| 446 | 33ms | 1 |
| 447 | rank-sums | 1 |
| 448 | energy/vitamins | 1 |
| 449 | al-class | 1 |
| 450 | pl-class | 1 |
| 451 | hemoglobinss | 1 |
| 452 | life-habits | 1 |
| 453 | between-components | 2 |
| 454 | drug-eluting-stents | 1 |
| 455 | rauisuchus | 1 |
| 456 | tiselius | 3 |
| 457 | cerus | 1 |
| 458 | viasys | 1 |
| 459 | acd/t | 1 |
| 460 | colorect | 1 |
| 461 | hpdt | 1 |
| 462 | insulet | 2 |
| 463 | gwet | 1 |
| 464 | ugeskrift | 2 |
| 465 | multi-unit | 1 |
| 466 | electron-volt | 1 |
| 467 | single-decrement | 2 |
| 468 | most-diseased-segment | 2 |
| 469 | nonevent | 1 |
| 470 | poleo-spearmint | 1 |
| 471 | 0-5-point | 1 |
| 472 | cvisept | 1 |
| 473 | 220-age-rest | 1 |
| 474 | jewett | 6 |
| 475 | re=eu | 4 |
| 476 | cefalu | 1 |
| 477 | eou | 3 |
| 478 | 11v | 1 |
| 479 | ∆lvesv | 1 |
| 480 | lprod=below | 1 |
| 481 | utw | 2 |
| 482 | beriplex | 1 |
| 483 | cnox | 1 |
| 484 | //www.annualreviews.org/catalog/pubdates.aspx | 1 |
| 485 | 3.3g/day | 1 |
| 486 | mumol/l/mg/kg/day | 1 |
| 487 | 2.5g/cow/day | 1 |
| 488 | 'self-efficacy | 1 |
| 489 | hiskey | 1 |
| 490 | eud=91gy | 1 |
| 491 | 10mg/daily | 1 |
| 492 | rationale-only | 1 |
| 493 | responder-only | 1 |
| 494 | haematology/biochemistry | 1 |
| 495 | 'validity | 1 |
| 496 | frequency*severity | 2 |
| 497 | ho2c-peg600-dtcz | 3 |
| 498 | hh₃ | 5 |
| 499 | alpo₄ | 1 |
| 500 | mersilene™ | 2 |
| 501 | searchlight™ | 1 |
| 502 | synergy1® | 1 |
| 503 | risperdal® | 1 |
| 504 | alfalastin® | 1 |
| 505 | il3-rα | 1 |
| 506 | simi'õ | 1 |